Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Current assets | |||||||||
Cash, cash equivalents and short term investments | -0.37%4.33M | --5.34M | --7.73M | 253.67%8.02M | 253.67%8.02M | --4.35M | 403.12%2.27M | --2.27M | --450.85K |
-Cash and cash equivalents | -0.37%4.33M | --5.34M | --7.73M | 253.67%8.02M | 253.67%8.02M | --4.35M | 403.12%2.27M | --2.27M | --450.85K |
Receivables | 25.64%8.52M | --7.21M | --7.39M | 426.46%2.97M | 426.46%2.97M | --6.78M | 44.67%564.28K | --564.28K | --390.06K |
-Accounts receivable | 25.64%8.52M | --7.21M | --7.39M | 426.46%2.97M | 426.46%2.97M | --6.78M | 44.67%564.28K | --564.28K | --390.06K |
Inventory | 90.90%482.25K | --436.86K | --379.32K | 22.01%350.35K | 22.01%350.35K | --252.62K | --287.15K | --287.15K | --0 |
Prepaid assets | 103.69%1.07M | --865.33K | --424.79K | 3,829.29%4.71M | 3,829.29%4.71M | --526.32K | 5.66%119.76K | --119.76K | --113.34K |
Other current assets | 6,355.39%1.18M | --4.04M | --4M | -60.49%40.4K | -60.49%40.4K | --18.26K | --102.26K | --102.26K | ---- |
Total current assets | 30.68%15.59M | --17.9M | --19.93M | 381.46%16.09M | 381.46%16.09M | --11.93M | 250.20%3.34M | --3.34M | --954.24K |
Non current assets | |||||||||
Net PPE | 15.45%4.01M | --3.67M | --3.92M | 49.18%4.05M | 49.18%4.05M | --3.47M | 189.12%2.72M | --2.72M | --939.9K |
-Gross PPE | 21.87%5.24M | --4.94M | --4.99M | 29.10%4.05M | 29.10%4.05M | --4.3M | 202.41%3.14M | --3.14M | --1.04M |
-Accumulated depreciation | -48.80%-1.23M | ---1.27M | ---1.07M | ---- | ---- | ---827.97K | -329.27%-422.66K | ---422.66K | ---98.46K |
Goodwill and other intangible assets | -3.67%27.01M | --27.27M | --27.52M | -4.46%27.78M | -4.46%27.78M | --28.04M | -4.56%29.08M | --29.08M | --30.47M |
-Goodwill | 0.00%27.01M | --27.01M | --27.01M | 0.00%27.01M | 0.00%27.01M | --27.01M | 0.00%27.01M | --27.01M | --27.01M |
-Other intangible assets | ---- | --257.01K | --514.02K | -62.74%771.03K | -62.74%771.03K | --1.03M | -40.15%2.07M | --2.07M | --3.46M |
Other non current assets | -21.82%491.16K | --235.44K | --207.85K | 0.00%62.14K | 0.00%62.14K | --628.22K | 508.62%62.14K | --62.14K | --10.21K |
Total non current assets | -1.96%31.51M | --31.18M | --31.65M | 0.12%31.9M | 0.12%31.9M | --32.14M | 1.40%31.86M | --31.86M | --31.42M |
Total assets | 6.88%47.1M | --49.07M | --51.59M | 36.32%47.99M | 36.32%47.99M | --44.07M | 8.74%35.2M | --35.2M | --32.37M |
Liabilities | |||||||||
Current liabilities | |||||||||
Payables | 41.94%4.86M | --3.39M | --4.6M | 1,153.09%3.79M | 1,153.09%3.79M | --3.42M | -55.29%302.11K | --302.11K | --675.71K |
-accounts payable | 41.94%4.86M | --3.39M | --4.6M | 1,811.45%3.79M | 1,811.45%3.79M | --3.42M | -70.69%198.06K | --198.06K | --675.71K |
-Due to related parties current | ---- | ---- | ---- | --0 | --0 | ---- | --104.06K | --104.06K | --0 |
Current accrued expenses | 44.56%1.81M | --1.44M | --1.04M | 949.82%3.87M | 949.82%3.87M | --1.25M | 167.67%369.08K | --369.08K | --137.89K |
Current debt and capital lease obligation | 0.25%995.27K | --805.16K | --900.18K | 34.23%944.47K | 34.23%944.47K | --992.78K | 244.21%703.64K | --703.64K | --204.42K |
-Current debt | -30.13%291.04K | --420.75K | --412.83K | 76.15%404.87K | 76.15%404.87K | --416.57K | 12.43%229.84K | --229.84K | --204.42K |
-Current capital lease obligation | 22.22%704.23K | --384.42K | --487.35K | 13.89%539.6K | 13.89%539.6K | --576.22K | --473.8K | --473.8K | --0 |
Current deferred liabilities | -69.78%601.68K | --279.9K | --585.81K | 337.18%5.02M | 337.18%5.02M | --1.99M | --1.15M | --1.15M | --0 |
Other current liabilities | 174,371,400.00%1.74M | --2.32M | --1.74M | ---- | ---- | --1 | ---- | ---- | ---- |
Current liabilities | 30.69%10.01M | --8.23M | --8.88M | 439.98%13.63M | 439.98%13.63M | --7.66M | 147.92%2.52M | --2.52M | --1.02M |
Non current liabilities | |||||||||
Long term debt and capital lease obligation | -9.36%1.86M | --1.64M | --1.81M | 44.54%2.03M | 44.54%2.03M | --2.05M | 159.93%1.4M | --1.4M | --539.26K |
-Long term debt | -56.65%567.56K | --1.18M | --1.28M | 69.31%1.39M | 69.31%1.39M | --1.31M | 52.19%820.71K | --820.71K | --539.26K |
-Long term capital lease obligation | 74.06%1.29M | --468.8K | --529.02K | 9.54%636.41K | 9.54%636.41K | --742.34K | --580.98K | --580.98K | --0 |
Derivative product liabilities | --690K | --828K | --1.66M | ---- | ---- | ---- | ---- | ---- | ---- |
Preferred securities outside stock equity | --15.86M | --15.46M | --15.08M | ---- | ---- | ---- | ---- | ---- | ---- |
Other non current liabilities | --1M | --1.5M | --1.5M | ---- | ---- | ---- | ---- | ---- | ---- |
Total non current liabilities | 846.18%19.41M | --19.44M | --20.05M | 44.54%2.03M | 44.54%2.03M | --2.05M | 159.93%1.4M | --1.4M | --539.26K |
Total liabilities | 202.96%29.42M | --27.67M | --28.93M | 298.78%15.65M | 298.78%15.65M | --9.71M | 152.08%3.93M | --3.93M | --1.56M |
Shareholders'equity | |||||||||
Share capital | --57.01M | --72.52M | --192.27M | ---- | ---- | ---- | ---- | ---- | ---- |
-common stock | --57.01M | --72.52M | --192.27M | ---- | ---- | ---- | ---- | ---- | ---- |
Retained earnings | ---43.21M | ---53.16M | ---169.61M | ---- | ---- | ---- | ---- | ---- | ---- |
Paid-in capital | --3.88M | --2.03M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
Total stockholders'equity | --17.68M | --21.4M | --22.66M | --32.33M | --32.33M | --0 | --0 | --0 | --0 |
Total equity | -48.55%17.68M | --21.4M | --22.66M | 3.38%32.33M | 3.38%32.33M | --34.36M | 1.49%31.28M | --31.28M | --30.82M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |